CEO SUMMARY: There’s a new contestant in the ongoing battle to win the Pap smear technology wars. Ampersand Medical Corporation, by signing a strategic alliance with AmeriPath, Inc., has signaled that it’s ready to bring its technology to market. AmeriPath will play a major role in expediting clinical studies and both companies hope to formally …
New Cytology Technology Entering Study Phase Read More »
